Journals / Türk Uyku Tıbbı Dergisi / 2020 / Cilt: 7 - Sayı: 1

Mean Platelet Volume in Patients With Obstructive SleepApnea Syndrome and Concurrent Hypertension andDiabetes Mellitus

Obstüktif Uyku Apneli ve Eşlik Eden Hipertansiyonlu ve Diabetes Mellituslu Hastalarda Ortalama Trombosit Hacmi

Pages
5–9
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: There were significant differences between the groups in desaturation index, Body Mass index, AHI, minimum oxygen saturation, and arousal (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Obstructive Sleep Apnea syndrome (OSAS) is a common disorder affecting especially middle-aged adults.
📊
Key Findings & Data:Patients whose AHI was 5-15 decided as mild, 15-30 as moderate, and above 30 was severe group.
💡
Conclusion & Impact:Results: There were significant differences between the groups in desaturation index, Body Mass index, AHI, minimum oxygen saturation, and arousal (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Obstructive Sleep Apnea syndrome (OSAS) is a common disorder affecting especially middle-aged adults. Elevated platelet activation and aggregation have a close relationship with cardiovascular complications. Mean platelet volume (MPV) is a marker of platelet activation. The influence of OSAS on platelet activation is not fully understood subject. Materials and Methods: One hundred ninety-two patients who were included in this study examined retrospectively with polysomnography. The Apnea-hypopnea index (AHI) above five was accepted as OSAS. The AHI under five was decided as control group. The OSAS group was categorized into three groups according to AHI values. Patients whose AHI was 5-15 decided as mild, 15-30 as moderate, and above 30 was severe group. The control group consist of 28 patients (14.6%), mild OSAS group consist of 31 patients (16.1%), moderate OSAS group consist of 42 patients (21.9%), and severe OSAS group consist of 91 patients (47.6%). The medical and sleep histories, demographic data, cardiovascular and metabolic histories, drug use of the patients were retrospectively examined. Laboratory analyze consisted of a routine blood evaluation. Hypertension and diabetes mellitus history also investigated. Results: There were significant differences between the groups in desaturation index, Body Mass index, AHI, minimum oxygen saturation, and arousal (p

Özet

Amaç: Obstrüktif Uyku Apne sendromu (OUAS) özellikle orta yaşerişkinleri etkileyen yaygın bir hastalıktır. Artmış platelet aktivasyon veagregasyonu ile kardiyovasküler komplikasyonlar arasında yakın birilişki mevcuttur. Ortalama trombosit hacmi, platelet aktivasyonununbir belirtecidir. OUAS’nin platelet aktivasyonu üzerine etkisi tam olarakanlaşılamamış bir konudur.Gereç ve Yöntem: Bu çalışmaya dahil edilen 192 hasta polisomnografi ileretrospektif olarak incelendi. Apne-hipopne indeksi (AHİ) beşin üzerindeolması OUAS olarak kabul edildi. AHİ beşin altında olanlar kontrol grubuolarak kararlaştırıldı. OUAS grubu apne-hipopne değerine göre üç grubaayrıldı. AHİ 5-15 arası olanlar hafif, 15-30 arası olanlar orta ve 30 üzeriolanlar ağır grup olarak ayrıldı. Kontrol grubu 28 hastadan (%14,6),hafif obstrüktif uyku apne grubu 31 hastadan (%16,1), orta obstrüktifuyku apne grubu 42 hastadan (%21,9) ve ağır obstrüktif uyku apnegrubu 91 hastadan (%47,6) oluşuyordu. Hastaların medikal ve uykuhikayeleri, demografik verileri, kardiyovasküler ve metabolik hikayesi, ilaçkullanımı retrospektif olarak incelendi. Laboratuar incelemesi rutin kandeğerlendirmesinden oluşuyordu. Hipertansiyon ve diabetes mellitushikayesi de ayrıca araştırıldı.Bulgular: Gruplar arasında Desatürasyon indeksi, Vücut Kitle indeksi,AHİ, minimum oksijen satürasyonu ve arousal arasında anlamlı farkmevcuttu (p

🔖

Cite This Article

GEÇKİL, A. A., KOCA, Ç. F. (2022). Mean Platelet Volume in Patients With Obstructive SleepApnea Syndrome and Concurrent Hypertension andDiabetes Mellitus. Türk Uyku Tıbbı Dergisi, Cilt: 7 - Sayı: 1, 5–9. https://ajindex.com/articles/643287

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Karakaş MS, Altekin RE, Baktır AO, Küçük M, Cilli A, Yalçınkaya S. Association between mean platelet volume and severity of disease in patients with obstructive sleep apnea syndrome without risk factors for cardiovascular disease. Turk Kardiyol Dern Ars 2013;41:14-20
  2. Kanbay A, Tutar N, Kaya E, Buyukoglan H, Ozdogan N, Oymak FS, Gulmez I, Demir R. Mean platelet volume in patients with obstructive sleep apnea syndrome and its relationship with cardiovascular diseases. Blood Coagul Fibrinolysis 2013;24:532-6
  3. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, GuggerM. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002;69:229-34
  4. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 2004;125:1768-75
  5. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O’Donnell CP, Adachi M. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007;175:612-7
  6. Varol E, Ozturk O, Gonca T, Has M, Ozaydin M, Erdogan D, Akkaya A. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010;70:497-502
  7. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195-205
  8. Akyol S, Çörtük M, Baykan AO, Kiraz K, Börekçi A, Şeker T, Gür M, Çayli M. Mean platelet volume is associated with disease severity in patients with obstructive sleep apnea syndrome. Clinics (Sao Paulo) 2015;70:481-5
  9. McNicholas WT, Bonsigore MR; Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78
  10. Sanner BM, Konermann M, Tepel M, Groetz J, Mummenhoff C, Zidek W. Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000;16:648-52
  11. Martin JF, Trowbridge EA, Salmon GL, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983;32:443-60
  12. Giles H, Smith RE, Martin JF. Platelet glycoprotein Iib-IIIa and size are increased in acute myocardial i